Doyoumoney

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating cash flow +	-55.31	-32.85	19.35	-20.12	-26.27
Net income
Depreciation, depletion and amortization	0.32	0.26	0.20	0.33	0.33
Stock-based compensation	10.04	6.80	2.22	1.93	1.75
Change in inventory
Other working capital changes	-65.67	-39.91	16.94	-22.38	-28.34
Cash flow from investing +	-3.71	-69.74	-65.57	22.30	-64.97
Capital expenditures	-0.23	-0.51	-0.41	-0.12	-0.17
Others incl. marketable securities changes	-3.48	-69.23	-65.15	22.42	-64.80
Cash flow from financing +	112.69	109.00	56.18	-1.24	79.84
Dividend payout
Common stock repurchases		0.00	-0.03	0.00	0.00
Net Debt Issuance	112.69	109.00	56.20	-1.24	79.84

Change in cash	53.66	6.42	9.96	0.94	-11.40

Show Quarterly Cash Flow

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22
Operating cash flow +	-16.27	-13.04	-12.20	-15.66	-14.41	-10.20	-6.17	-8.36	-8.12	-10.70	-5.38	40.67	-5.24	-4.08
Net income
Depreciation, depletion and amortization	0.08	0.09	0.08	0.08	0.08	0.08	0.06	0.06	0.06	0.04	0.04	0.04	0.07	0.08
Stock-based compensation	3.82	2.48	2.57	2.42	2.57	2.25	2.29	0.62	0.77	0.76	0.48	0.49	0.49	0.49
Change in inventory
Other working capital changes	-20.17	-15.61	-14.85	-18.16	-17.06	-12.53	-8.52	-9.04	-8.94	-11.50	-5.90	40.14	-5.81	-4.65
Cash flow from investing +	-39.31	-47.45	14.94	13.88	14.92	-9.39	-30.18	-38.90	8.73	9.03	-39.50	-44.46	9.36	4.92
Capital expenditures	-0.31	-0.04	-0.10	-0.04	-0.05	-0.17	-0.08	-0.12	-0.15	-0.31	-0.02	-0.03	-0.05	0.00
Others incl. marketable securities changes	-39.00	-47.41	15.04	13.93	14.96	-9.22	-30.10	-38.78	8.88	9.34	-39.47	-44.43	9.41	4.92
Cash flow from financing +	0.13	93.47	19.11	0.09	0.02	0.64	0.01	108.22	0.12	-0.32	10.33	46.79	-0.62	-0.63
Dividend payout
Common stock repurchases										0.00				0.00
Net Debt Issuance	0.13	93.47	19.11	0.09	0.02	0.64	0.01	108.22	0.12	-0.32	10.33	46.79	-0.62	-0.63

Change in cash	-55.45	32.97	21.85	-1.69	0.53	-18.95	-36.34	60.97	0.74	-2.00	-34.55	43.01	3.49	0.22

Cash Flow - Contineum Therapeutics, Inc. (CTNM)